INSPIRE-CF: an Alternative Physiotherapy Model for Children With Cystic Fibrosis (INSPIRE-CF)

INSPIRE-CF: A Randomised Controlled Trial Investigating the Clinical and Economic Benefits of an Alternative Model of Physiotherapy Care for Children With Cystic Fibrosis

The primary aim of the research is to evaluate whether an alternative model of cystic fibrosis (CF) physiotherapy care can produce statistically significant improvements in clinical and patient reported outcomes, and whether this alternative model is economically advantageous and/or sustainable.

Children randomised to the control group will receive 24-months of current model of CF care at Great Ormond Street Hospital (GOSH).

Children randomised to the intervention group will receive 24-months of current model of CF care at GOSH PLUS a weekly structured, individually prescribed and personally supervised exercise intervention at a local fitness facility or at school. The exercise prescription will include aerobic, anaerobic, strength, core conditioning and stretching components.

The main objectives of the study are:

1. Determine differences, if any, in lung function between the two groups;
2. Determine differences, if any, in exercise capacity between the two groups;
3. Evaluate cost of care of alternate model of care versus current model of care.

Study Overview

• Status: Completed
• Conditions: Cystic Fibrosis
• Intervention / Treatment: Other: Exercise Intervention

• Study Type: Interventional
• Enrollment (Actual): 71
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • London, United Kingdom, WC1N 3JH
    • Great Ormond Street Hospital For Children NHS Foundation Trust

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 years to 15 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patients with a documented diagnosis of Cystic Fibrosis;
• Male or female aged 6 years or older at baseline and <17years old at the end of the 2-year study;
• Currently under the primary care of the GOSH CF Unit;
• Able to perform Spirometry with a baseline FEV1 percentage predicted of 40% or higher, as measured on at least 3 occasions in the previous year, during times of clinical stability (i.e. not during an exacerbation, and not during or within 2 weeks of intravenous antibiotics);
• The participant's parent or legal guardian must be able to give informed consent; assent will be sought from all children.

Exclusion Criteria:

• Patients who have had lung transplantation;
• Patients listed for lung transplantation;
• Clinically significant disease or medical condition other than CF or CF-related conditions that in the opinion of the multi-disciplinary clinical team, would compromise the safety of the patient;
• Orthopaedic impairment that compromises exercise performance;
• Mental impairment leading to inability to cooperate;
• Unable to understand both verbal and/or written instructions English. Children will need to be able to understand exactly what the physiotherapists are instructing them do, for safe and effective exercise training sessions. Information sheets and questionnaires are only available in English;
• Participants, parents or legal guardians who are unwilling to sign consent to participate in the study.

The following criteria will not exclude a child from participating in the study, but based on the hospital's exercise laboratory's infection control protocol, may preclude the participant from Cardiopulmonary Exercise Testing.

• Patients with Methicillin-Resistant Staphylococcus Aureus;
• Patients with Burkholderia Cepacia.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Group 1: Control; Control Group (Arm 1): Children randomised to the control group will receive 24-months of current model of specialist CF care.
Active Comparator: Group 2: Exercise Intervention; Intervention group (Arm 2): Children randomised to the intervention group will receive 24-months of current model of specialist CF care PLUS a weekly structured, individually prescribed and personally supervised exercise intervention at a local fitness facility or at school.	Other: Exercise Intervention; The exercise intervention will include aerobic, anaerobic, strength, core conditioning and stretching components.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Forced expiratory volume in one second (FEV1)	Spirometry data will also to be collected at outpatient clinics, annual reviews and during hospital admissions.	Baseline, 6, 12 and 24-month intervals.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Peak oxygen uptake (VO2Peak)	Gold standard exercise test to determine peak oxygen uptake during exercise	Baseline, 12 and 24-month intervals
10m-Modified Shuttle Walk Test	Field test to assess functional exercise capacity. Distance covered and incremental level changes are evaluated over time.	Baseline, 6, 12 and 24 months
Lung Clearance Index	Multiple breath washout test to evaluate for changes in small airways	Baseline, 12 and 24 months
Height, weight, body mass index measurements	Height, weight and body mass index will be measured at regular intervals to evaluate for changes in growth parameters	Baseline, 6, 12 and 24 months
Cystic Fibrosis Questionnaire	Disease specific questionnaire to evaluate changes in quality of life in cystic fibrosis	Baseline, 12 and 24 months
Cost of care	Evaluate differences in cost of care between the current model of CF care and the alternative model of care; and cost per patient.	Baseline, 12 and 24 months

Collaborators and Investigators

• Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust
• Investigators: Principal Investigator: Sean J Ledger, BSc MSc, Cystic Fibrosis Unit, Great Ormond Street Hospital for Children NHS Foundation Trust; Principal Investigator: Eleanor Main, BA MSc PhD, Institute of Child Health, University College London

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2012
• Primary Completion (Actual): December 31, 2017
• Study Completion (Actual): December 31, 2017

Study Registration Dates

• First Submitted: June 11, 2013
• First Submitted That Met QC Criteria: June 26, 2013
• First Posted (Estimate): July 1, 2013

Study Record Updates

• Last Update Posted (Actual): September 6, 2019
• Last Update Submitted That Met QC Criteria: September 4, 2019
• Last Verified: September 1, 2019

More Information

Terms related to this study

• Keywords: lung function; exercise; quality of life; physiotherapy
• Additional Relevant MeSH Terms: Digestive System Diseases; Pathologic Processes; Respiratory Tract Diseases; Lung Diseases; Infant, Newborn, Diseases; Genetic Diseases, Inborn; Pancreatic Diseases; Fibrosis; Cystic Fibrosis
• Other Study ID Numbers: 11AR13